Prevalence of hepatitis A in an institution for the mentally retarded in an intermediate endemicity area: Influence of age length of institutionalizatian

Journal of Infection

Volumn 38, Issue 2, 1999, Pages 120-123

  Gil, A ^a   Gonzalez A ^b   Dal Re R ^b   Dominguez, V ^a   Ortega, P ^a   Barrio, J L ^a   Aguilar, L ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD SAMPLING; DEMOGRAPHY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MENTAL HOSPITAL; PREVALENCE; RISK; SCHOOL CHILD; SPAIN;

EID: 0032892987     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90080-4     Document Type: Article

References (14)

1. Battegay M, Gust ID, Feinstone S, et al. eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995; 1636-1655.
2. Hadler SC. Global impact of Hepatitis A Virus infection changing patterns. In: Hollinger FB, Lemon SM, Margolis HS eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins 1991: 14-20.
3. Szmuness W, Purcell RH, Diennstag JL, Stevens CE. Antibody to hepatitis A antigen in institutionalized mentally retarded patients. JAMA 1977; 237: 1702-1705.
4. Lehmann NI, Sharma DLB, Gust ID. Prevalence of antibody to the hepatitis A virus in a large institution for the mentally retarded. J Med Virol 1978; 2: 335-339.
5. Bell JC, Crewe EB, Capon AG. Seroprevalence of hepatitis A antibodies among residents of a centre for people with developmental disabilities. Aust NZ J Med 1994; 24: 365-366.
6. Perez-Trallero E, Cilla G, Urbieta M, Dorronsoro M, Otero F, Marimon JM. Falling incidence and prevalence of hepatitis A in Nothern Spain. Scand J Infect Dis 1994; 26: 133-136.
7. Chiaramonte M, Moschen ME, Stroffolini T et al. Changing epidemiology of hepatitis A virus (HAV) infection: A comparative seroepidemiological study (1979 vs 1989) in north-east Italy. Ital J Gastroenterol 1991; 23: 344-346.
8. Papaevangelou G. Epidemiology of hepatitis A in Mediterranean countries. Vaccine 1992; 10 (suppl 1): S63-S66.
9. Gonzalez A, Bruguera M, Calbo-Torrecillas F et al. Encuesta seroepidemiologica de prevalencia de anticuerpos antihepatitis A en la población adulta joven espñola. Med Clin (Barc) 1994; 103: 445-448.
10. Gil A, Gonzalez A, Dal-Re R, Ortega P, Dominguez V. Seroprotección frente a hepatitis A. sarampion, rubeola y parotidits en una población escolar urbana. Med Clin (Barc) 1991; 96: 681-684.
11. Gil A, Gonzalez A, Dal-Re R, Dominguez V, Astasio P, Aguilar L. Detection of antibodies against hepatitis A in blood spots dried on filter paper. Is this a reliable method for epidemiological studies. Epidemiol Infect 1997; 118: 189-191.
12. Lwanga SK, Lemeshow S. Sample size determination in health studies. A Practical Manual. Geneva: World Health Organization, 1991.
13. Centers for Disease Control. Prevention of Hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45: 8-24.
14. Laurischesse H, Peigue-Lafeuille H, Rabanel JR, Henquell C, Beytout J, Rey M. Une epidemie d'hepatite A dans un establissment pour handicapes rapidement enrayee par la sero-vaccination des residents et du personnel. In: 13th Interdisciplinary Meeting on Anti-Infectious Chemotherapy; 2-3 December 1993, Paris, France. Abstract 286/P15.